Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT)

February 23, 2010 updated by: University of Zurich

A Randomized Controlled Study to Evaluate the Short- and Long-term Effectiveness of an Individualized Resource Oriented Occupational Therapy for Patients With Rheumatoid Arthritis

The purpose of the study is to compare the short- and long-term effectiveness of an individualized, resource-oriented joint protection intervention with the standard, problem-oriented joint protection intervention for patients with rheumatoid arthritis.

Study Overview

Status

Completed

Detailed Description

Joint Protection (JP)is an important intervention in the management of people with arthritis. Altering working methods (e.g. use of proximal joints, dynamic activities), energy conservation (balance between activity and rest) and using assistive devices should place less strain on joint structures weakened by the disease process. These strategies ought to decrease pain and stress on joints, improve function, and facilitate maintaining social roles.

The effectiveness of JP has been evaluated in a number of studies, all in a group setting. JP has beneficial short-term effects on pain and function in patients with established RA and moderate functional problems. Using assistive devices reduces pain during task performance in comparison to normal methods and altering working methods significantly reduces difficulties in activities of daily living (ADL). However this generally does not result in significant behavioral changes and a long-term impact on reducing pain and maintaining function may only be reached if JP is taught using behavioral education methods. Additionally, adherence of RA patients to different interventions is generally modest, which may well determine the effectiveness of any given intervention, especially in the long-term.

All previous studies were carried out in group settings, however, in Switzerland, standard JP education is provided on a one-to-one basis and an individualized education is assumed to be a promising approach.

This clinical trial aims to test the hypothesis that an individualized, resource-oriented JP education in RA patients leads to a better therapy success in the short and long-term, compared to problem-oriented standard JP education in terms of joint protection behavior. Secondary outcome parameters are self-perception, general and specific self-efficacy and general and health-related quality of life.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3010
        • University Hospital
      • Valens, Switzerland, 7317
        • Rehabilitation Clinic
      • Zurich, Switzerland, 8008
        • Schulthess Klinik
      • Zurich, Switzerland, 8091
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of RA according to ACR Guidelines (1988)
  • Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation
  • Referred to OT for a Joint Protection intervention program
  • Willingness to comply with the randomly assigned treatment and informed consent
  • Functional Class: 2 to 4
  • German speaking/understanding/reading
  • Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation

Exclusion Criteria:

  • Functional class 1 (anticipated self-exclusion, as patients in class 1 will not be referred to JP).
  • Severe finger, hand, elbow or shoulder deformities
  • Insufficient ability to understand, speak and read the German language
  • Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: standard joint protection education
psycho-educational joint protection vs. usual care (standard joint protection education)
individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
joint protection behavior
Time Frame: before/after intervention, 3,6,12 months follow up
before/after intervention, 3,6,12 months follow up

Secondary Outcome Measures

Outcome Measure
Time Frame
General quality of life
Time Frame: before intervention, 3,6,12 months follow up
before intervention, 3,6,12 months follow up
Health related quality of life / physical functional ability
Time Frame: before intervention, 6,12 months follow up
before intervention, 6,12 months follow up
Self-Illness Separation SIS, derived from the PRISM (intervention group)
Time Frame: before/during/after intervention, 3,6,12 months follow up
before/during/after intervention, 3,6,12 months follow up
Goals achievement (intervention group)
Time Frame: during/after intervention, 3,6,12 months follow up
during/after intervention, 3,6,12 months follow up
Hand impairment status, including pain
Time Frame: before/during/after intervention, 3,6,12 months follow up
before/during/after intervention, 3,6,12 months follow up
Arthritis self-efficacy and JP-specific self-efficacy
Time Frame: before/after intervention, 3,6,12 months follow up
before/after intervention, 3,6,12 months follow up
Self-perceived disease activity
Time Frame: before intervention, 12 months follow up
before intervention, 12 months follow up
Clinical data
Time Frame: before intervention, 3, 12 months follow up
before intervention, 3, 12 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Robert de Bie, Prof, PhD, University of Maastricht NL
  • Principal Investigator: Karin Niedermann, MPH, University Hospital of Zurich, CH
  • Study Director: Stefan Buchi, MD, University Hospital of Zurich, CH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2006

Primary Completion (Actual)

February 1, 2009

Study Completion (Actual)

September 1, 2009

Study Registration Dates

First Submitted

November 15, 2006

First Submitted That Met QC Criteria

November 15, 2006

First Posted (Estimate)

November 17, 2006

Study Record Updates

Last Update Posted (Estimate)

February 24, 2010

Last Update Submitted That Met QC Criteria

February 23, 2010

Last Verified

February 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on psycho-educational Joint protection education

3
Subscribe